Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a...

Pozniak, Anton; Arribas, Jose R.; Gathe, Joseph; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 71(5):530-537, April 15, 2016.

Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s

Longenecker, Chris T.; Kitch, Douglas; Sax, Paul E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 69(2):168-177, June 1, 2015.

Changes in Proteinuria and Albuminuria With Initiation of Antiretroviral Therapy: Data From a Randomized Trial Comparing Tenofovir Disoproxil Fumarate/Emtricitabine Versus...

Wyatt, Christina M.; Kitch, Douglas; Gupta, Samir K.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 67(1):36-44, September 1, 2014.

Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function: A Randomized, Controlled Trial

Gupta, Samir K.; Mi, Deming; Moe, Sharon M.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 64(3):279-283, November 1, 2013.